Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Atrophic Maxilla

ClinicalTrials.gov lists 24 trials for Atrophic Maxilla or a narrower condition beneath it. Nobel Biocare has the most among industry and government lead sponsors, with 1.

MeSH D000099066 Musculoskeletal Diseases C05 C07
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Not applicable Not applicable 21 Observational Observational 3 Not applicable Not applicable 21 Observational Observational 3

Trials per phase

24 of the 24 trials are tagged with Atrophic Maxilla itself; the rest are tagged with a narrower condition beneath it.

Get the Atrophic Maxilla report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Atrophic Maxilla trials start? (12)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials over time, by phase

  • Not applicable
  • Observational

Top of scale: 5

2014: 1 trials (Observational 1) 2015: 1 trials (Not applicable 1) 2017: 1 trials (Not applicable 1) 2018: 1 trials (Not applicable 1) 2019: 1 trials (Not applicable 1) 2020: 1 trials (Not applicable 1) 2021: 1 trials (Not applicable 1) 2022: 1 trials (Not applicable 1) 2023: 5 trials (Observational 1, Not applicable 4) 2024: 3 trials (Not applicable 3) 2025: 5 trials (Not applicable 5)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 3
2025 5
2024 3
2023 5
2022 1
2021 1
2020 1
2019 1
2018 1
2017 1

No forecast is made for this condition: it averages 3.4 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: 3 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Atrophic Maxilla trials in? (2)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Not applicable 21
Observational 3

How many Atrophic Maxilla trials are recruiting? (4)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Not yet recruiting 5
Recruiting 4
Completed 12
Unknown status 3

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which lead sponsors run the most Atrophic Maxilla trials? (1)

Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Lead sponsors
Sponsor Trials
Nobel Biocare 1

Which drugs are being tested for Atrophic Maxilla? (3)

Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.

Drugs tested
Drug Trials
Leukocyte Platelet Rich Fibrin 1
B 1
A- PRF 1

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, publications, prevalence, rare-disease identity, and sub-conditions in mesh.

Browse all condition evidence pages